Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Funding and backers

Total raised
$13.6M
2 rounds on record
Latest round
$5.6M
Series A · Dec 2024 · 21 mo ago
Team
11-50
employees, estimated range
Hiring now
3
+1 posted in 30 days
Backers
2
aMoon, APEX Ventures
The money's age
Due for its next round
21 months since the last round · and hiring
Momentum
28/100
hiring for its size, in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 3 Launched Lyfegen Unveils Generative AI to Transform Drug Contracting and Accelerate Patient Access · YahooFinance Jan 28, 2025 Partnership Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights · PRNewswire Dec 11, 2024 Raised a round Series A $5.6M · PRNewswire Sep 20, 2022 Raised a round Series A $8M
Funding rounds
RoundDateAmountInvestorsSource
Series A Dec 2024 $5.6M — PRNewswire
Series A Sep 2022 $8M — mobihealthnews.com
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
ClinicientVenture round $17.3M · 7 yr ago • 51-200 employees
Clinicient’s Insight Platform streamlines operations and improves outcomes for PT, OT, and SLP organizations of all sizes.
CuredVenture round $2.5M · 7 yr ago • Founded 2019 • 51-200 employees
Experience healthcare transformation with Cured's intelligent platform. Drive patient engagement, improve outcomes, and accelerate revenue…
CARE by MarianaAI harnesses healthcare's best AI Copilots to ambiently transcribe and document encounters, provide decision support in…
CardamomVenture round $1.5M · 2 yr ago • Founded 2021 • 11-50 employees
Cardamom is a professional services healthcare IT company specializing in data, analytics, AI, and applications to maximize and improve…
Knowtex11-50 employees • 4 roles
Knowtex automates clinical workflows with AI-powered voice technology, reducing documentation time and improving healthcare efficiency…
SolaceSeries C $130M · 7 mo ago • Founded 2022 • 51-200 employees • 22 roles
Solace is on a health tech startup mission to empower patients, improve outcomes, and restore the promise of the U.S. healthcare system.

Overview

Discover Lyfegen’s solutions for healthcare efficiency. Optimize revenue and improve outcomes with our reliable solutions.

News

News pharmexec.com 4 days ago
EVERSANA Partners with Lyfegen to Bring AI to Drug Pricing and Market Access PharmExec
The two companies will combine existing assets in order to find new connections and opportunities.
Read more
Report
News pharmaphorum 6 days ago
Lyfegen partners EVERSANA on pricing, access resource
Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment.
Read more
Report
News YahooFinance 7 months ago
Lyfegen Unveils Generative AI to Transform Drug Contracting and Accelerate Patient Access
Lyfegen, a global provider of innovative drug access, contracting and rebate management solutions, announced today the launch of its AI Contracting Companion. This AI solution is designed to support pharmaceutical organizations navigating through increasi
Read more
Report
News YahooFinance 1 year ago
Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights
Lyfegen, a global innovator in drug market access, pricing, and rebate management, has announced a transformative collaboration with EVERSANA, a leading provider of global commercial services to the life sciences industry, to revolutionize drug pricing an
Read more
Report
Press release PRNewswire 1 year ago
Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights
/PRNewswire/ -- Lyfegen, a global innovator in drug market access, pricing, and rebate management, has announced a transformative collaboration with EVERSANA,...
Read more
Report
Press release PRNewswire 2 years ago
Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally
/PRNewswire/ -- Lyfegen, a global leader in drug rebate management technology, today announced the successful close of its additional CHF 5 million Series A...
Read more
Report
News NLHealthServices 2 years ago
NL Health Services Partners to Improve Pharmaceutical Rebates
Newfoundland and Labrador (NL) Health Services and Lyfegen, a global rebate management software provider headquartered in Switzerland…
Read more
Report
News Business Insider 4 years ago
See the 11-slide pitch deck that Lyfegen used to win over investors on its approach to lower drug costs
Drug prices can often make lifesaving drugs difficult to get. Lyfegen, a value-based contracting company, just raised $8 million to change this.
Read more
Report
News MedCity News 4 years ago
Lyfegen raises $8M for its value-based drug contracting platform
Lyfegen, a startup that provides software for value-based drug contracting, recently raised $8 million in an oversubscribed Series A financing round. With the new funds, the company - which is based in Switzerland and New York - plans to expand its presen
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Lyfegen over the last 12 months, by layer, with the share of postings for each.
Technologies in use
5
Postings analysed
2
Stack modernity
86/100AI adopter
Languages
Python
SAS
SQL
AI & ML
ChatGPT
Claude
Sign in to see how your skills match this stack Sign In

Growth

Hiring Momentum
28/100
Slowing
Open positions
3
0 opened / 0 closed in 30 days
ATS activity
Every ~3 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Analytics
50% ▲
Customer Success
50% ▼

Jobs

In office • Full-Time • Bachelor's Degree
Python
SQL
SAS
Apply

Financials

Total raised
$13.6M
Latest round
Series A
Funding rounds
2
Funding rounds
Round Announced Amount
Series A 2024 $5.6M Details
Series A 2022 $8M Details